RENAL DISEASE A post-hoc analysis of the SURPASS-4 compared the effect of tirzepatide and glargine insulin on kidney function with a median treatment duration of treatment of 85 weeks (401)
Workers with obesity have roughly 76% higher short-term disability rates than their normal-weight colleagues, meaning every employee who gains stable access to effective obesity treatment is statistically far less likely to go out on disability leave
For weight management, medications like Wegovy (semaglutide 2.4mg) are restricted to specialist weight management services with specific eligibility criteria
Additionally, scientists discovered that up to 72.3% of participants in the treatment group lower their weight by at least 5%
The time investment is significant
By investing in manufacturing capacity, leveraging digital technologies, and enhancing cold chain infrastructure, the pharmaceutical industry can ensure that these life-changing medications are available to everyone who needs them, regardless of location
